Literature DB >> 25048748

Can we improve the targeting of respiratory syncytial virus (RSV) prophylaxis in infants born 32-35 weeks' gestational age with more informed use of risk factors?

Xavier Carbonell-Estrany1, John R Fullarton, Barry S Rodgers-Gray, Katherine L Gooch, Pamela G Vo, Jose Figueras-Aloy.   

Abstract

OBJECTIVE: To evaluate the key risk factors for respiratory syncytial virus (RSV) hospitalisation in 32-35 weeks' gestational age (wGA) infants.
METHODS: Published risk factors were assessed for predictive accuracy (area under the receiver operating characteristic curve [ROC AUC]) and for number needed to treat (NNT).
RESULTS: Key risk factors included: proximity of birth to the RSV season; having siblings; crowding at home; day care; smoking; breast feeding; small for GA; male gender; and familial wheezing/eczema. Proximity of birth to the RSV season appeared the most predictive. Risk factors models from Europe and Canada were found to have a high level of predictive accuracy (ROC AUC both > 0.75; NNT for European model 9.5). A model optimised for three risk factors (birth ± 10 weeks from start of RSV season, number of siblings ≥ 2 years and breast feeding for ≤ 2 months) had a similar level of prediction (ROC AUC: 0.776; NNT: 10.2). An example two-risk factor model (day care attendance and living with ≥ 2 siblings < 5 years old) had a lower level of predictive accuracy (ROC AUC: 0.55; NNT: 26).
CONCLUSIONS: An optimised combination of risk factors has the potential to improve the identification of 32-35 wGA infants at heightened risk of RSV hospitalisation.

Entities:  

Keywords:  Bronchiolitis; NNT; hospitalisation; palivizumab; premature infants

Mesh:

Substances:

Year:  2014        PMID: 25048748     DOI: 10.3109/14767058.2014.947573

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  3 in total

1.  Cost-effectiveness of palivizumab compared to no prophylaxis in term infants residing in the Canadian Arctic.

Authors:  Anna Banerji; Kaspar Ng; Theo J Moraes; Vladimir Panzov; Joan Robinson; Bonita E Lee
Journal:  CMAJ Open       Date:  2016-10-18

Review 2.  The Role of Human Milk Immunomodulators in Protecting Against Viral Bronchiolitis and Development of Chronic Wheezing Illness.

Authors:  Dani-Louise Dixon
Journal:  Children (Basel)       Date:  2015-07-07

3.  Positive association of breastfeeding on respiratory syncytial virus infection in hospitalized infants: a multicenter retrospective study.

Authors:  Min Jeong Jang; Yong Joo Kim; Shinhye Hong; Jaeyoon Na; Jong Hee Hwang; Son Moon Shin; Young Min Ahn
Journal:  Clin Exp Pediatr       Date:  2019-11-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.